Anti-elastolytic activity of a honeybee (Apis cerana) chymotrypsin inhibitor

Biochemical and Biophysical Research Communications

Volumn 430, Issue 1, 2013, Pages 144-149

  Kim, Bo Yeon ^a   Lee, Kwang Sik ^a   Wan, Hu ^a   Zou, Feng Ming ^a   Choi, Yong Soo ^b   Yoon, Hyung Joo ^b   Kwon, Hyung Wook ^c   Je, Yeon Ho ^c   Jin, Byung Rae ^a  

^a Dong A University   (South Korea)

^b National Academy of Agricultural Science   (South Korea)

^c Seoul National University   (South Korea)

Author keywords

Anti elastolytic factor; Apis cerana; Bee; Chymotrypsin inhibitor; Elastase inhibitor

Indexed keywords

CHYMOTRYPSIN INHIBITOR;

ALTERNATIVE MEDICINE; ANTIELASTOLYTIC ACTIVITY; ARTICLE; DRUG ACTIVITY; ENZYME INHIBITION; GENE SEQUENCE; HONEYBEE; MOLECULAR CLONING; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

AMINO ACID SEQUENCE; ANIMALS; BEES; CHYMOTRYPSIN; INSECT PROTEINS; MOLECULAR SEQUENCE DATA; PANCREATIC ELASTASE; SERINE PROTEINASE INHIBITORS;

APIS CERANA; APIS MELLIFERA; APOIDEA; HEXAPODA;

EID: 84872383355     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.11.056     Document Type: Article

References (30)

1. Velthuis H.H.W., van Doorn A. A century of advances in bumblebee domestication and the economic and environmental aspects of its commercialization for pollination. Apidologie 2006, 37:421-451.
2. Cherniack E.P. Bugs as drugs, part 1: insects. The " new" alternative medicine for the 21st century?. Alternat. Med. Rev. 2010, 15:124-135.
3. Hider R.C. Honeybee venom: a rich source of pharmacologically active peptides. Endeavour 1988, 12:60-65.
4. Son D.J., Lee J.W., Lee Y.H., Song H.S., Lee C.K., Hong J.T. Therapeutic application of anti-arthritis, pain-releasing, and anti-cancer effects of bee venom and its constituent compounds. Pharmacol. Ther. 2007, 115:246-270.
5. Choo Y.M., Lee K.S., Yoon H.J., Kim B.Y., Sohn M.R., Roh J.Y., Je Y.H., Kim N.J., Kim I., Woo S.D., Sohn H.D., Jin B.R. Dual strategy of bee venom serine protease: prophenoloxidase-activating factor in arthropods and fibrin(ogen)olytic enzyme in mammals. PLoS One 2010, 5:e10393.
6. Qiu Y., Choo Y.M., Yoon H.J., Jia J., Cui Z., Wang D., Kim D.H., Sohn H.D., Jin B.R. Fibrin(ogen)olytic activity of bumblebee venom serine protease. Toxicol. Appl. Pharmacol. 2011, 255:207-213.
7. Choo Y.M., Lee K.S., Yoon H.J., Qiu Y., Wan H., Sohn M.R., Sohn H.D., Jin B.R. Antifibrinolytic role of a bee venom serine protease inhibitor that acts as a plasmin inhibitor. PLoS One 2012, 7:e32269.
8. Babin D.R., Peanasky R.J., Goss S.M. The isoinhibitors of chymotrypsin/elastase from Ascaris lumbricoides: the primary structure. Arch. Biochem. Biophys. 1984, 232:143-161.
9. Huang K., Strynadka N.C.J., Bernard V.D., Peanasky R.J., James M.N.G. The molecular structure of the complex of Ascaris chymotrypsin/elastase inhibitor with porcine elastase. Structure 1994, 2:679-689.
10. Bania J., Stachowiak D., Polanowski A. Primary structure and properties of the cathepsin G/chymotrypsin inhibitor from the larval hemolymph of Apis mellifera. Eur. J. Biochem. 1999, 262:680-687.
11. Cierpicki T., Bania J., Otlewski J. NMR solution structure of Apis mellifera chymotrypsin/cathepsin G inhibitor-1 (AMCI-1): structural similarity with Ascaris protease inhibitors. Protein Sci. 2000, 9:976-984.
12. Rhoads M.L., Fetterer R.H., Hill D.E., Urban J.F. Trichuris suis: a secretory chymotrypsin/elastase inhibitor with potential as an immunomodulator. Exp. Parasitol. 2000, 95:36-44.
13. Söllner C., Mentele R., Eckerskorn C., Fritz H., Sommerhoff C.P. Isolation and characterization of hirustasin, an antistasin-type serine-proteinase inhibitor from the medical leech Hirudo medicinalis. Eur. J. Biochem. 1994, 219:937-943.
14. Chang L.S., Chung C., Huang H.B., Lin S.R. Purification and characterization of a chymotrypsin inhibitor from the venom of Ophiophagus hannah (king cobra). Biochem. Biophys. Res. Commun. 2001, 283:862-867.
15. Zhou X.D., Jin Y., Lu Q.M., Li D.S., Zhu S.W., Wang W.Y., Xiong Y.L. Purification, characterization and primary structure of a chymotrypsin inhibitor from Naja atra venom. Comp. Biochem. Physiol. B 2004, 237:219-220.
16. He Y.Y., Liu S.B., Lee W.H., Qian J.Q., Zhang Y. Isolation, expression and characterization of a novel dual serine protease inhibitor, OH-TCI, from king cobra venom. Peptides 2008, 29:1692-1699.
17. Lu J., Yang H., Yu H., Gao W., Lai R., Liu J., Liang X. A novel serine protease inhibitor from Bungarus fasciatus venom. Peptides 2008, 29:369-374.
18. Soares T.S., Watanabe R.M.O., Tanaka-Azevedo A.M., Torquato R.J.S., Lu S., Figueiredo A.C., Pereira P.J.B., Tanaka A.S. Expression and functional characterization of boophilin, a thrombin inhibitor from Rhipicephalus (Boophilus) microplus midgut. Vet. Parasitol. 2012, 187:521-528.
19. Tsujimoto H., Kotsyfakis M., Francischetti L.M.B., Eum J.H., Strand M.R., Champagne D.E. Simukunin from the salivary glands of the black fly Simulium vittatum inhibits enzymes that regulate clotting and inflammatory responses. PLoS One 2012, 7:e29964.
20. Masci P.P., Whitaker A.N., Sparrow L.G., de Jersey J., Winzor D.J., Watters D.J., Lavin M.F., Gaffney P.J. Textilinins from Pseudonaja textilis. Characterization of two plasmin inhibitors that reduce bleeding in an animal model. Blood Coagul. Fibrinolysis 2000, 11:385-393.
21. Flight S.M., Johnson L.A., Du Q.S., Warner R.L., Trabi M., Gaffney P.J., Lavin M.F., de Jersey J., Masci P.P. Textilinin-1, an alternative anti-bleeding agent to aprotinin: importance of plasmin inhibition in controlling blood loss. Br. J. Hematol. 2009, 145:207-211.
22. Flight S., Johnson L., Trabi M., Gaffney P., Lavin M., de Jersey J., Masci P. Comparison of textinin-1 with aprotinin as serine protease inhibitors and as antifibrinolytic agents. Pathophysiol. Haemost. Thromb. 2005, 34:188-193.
23. Corral-Rodríguez M.á., Macedo-Ribeiro S., Pereira P.J.B., Fuentes-Prior P. Tick-derived Kunitz-type inhibitors as antihemostatic factors. Insect Biochem. Mol. Biol. 2009, 39:579-595.
24. Chen Z.Y., Hu Y.T., Yang W.S., He Y.W., Feng J., Wang B., Zhao R.M., Ding J.P., Cao Z.J., Li W.X., Wu Y.L. Hg1, novel peptide inhibitor specific for Kv1.3 channels from first scorpion Kunitz-type potassium channel toxin family. J. Biol. Chem. 2012, 287:13813-13821.
25. The honeybee genome sequencing consortium, Insights into social insects from the genome of the honeybee Apis mellifera, Nature 443 (2006) 931-949.
26. Alam S.R., Newby D.E., Henriksen P.A. Role of the endogenous elastase inhibitor, elafin, in cardiovascular injury from epithelium to endothelium. Biochem. Pharmacol. 2012, 83:695-704.
27. Je Y.H., Chang J.H., Choi J.Y., Roh J.Y., Jin B.R., O'Reilly D.R., Kang S.K. A defective viral genome maintained in Escherichia coli for the generation of baculovirus expression vectors. Biotechnol. Lett. 2001, 23:575-582.
28. Sinauridze E.I., Romanov A.N., Gribkova I.V., Kondakova O.A., Surov S.S., Gorbatenko A.S., Butylin A.A., Monakov M.Y., Bogolyubov A.A., Kuznetsov Y.V., Sulimov V.B., Ataullakhanov F.I. New synthetic thrombin inhibitors: molecular design and experimental verification. PLoS One 2011, 6:e19969.
29. Qiu Y., Yoon H.J., Jin B.R. Molecular cloning and characterization of chymotrypsin inhibitor and chitin-binding protein homologs from the bumblebee Bombus terrestris. Int. J. Indust. Entomol. 2012, 25:115-121.
30. Laskowski M., Kato I. Protein inhibitors of proteinases. Annu. Rev. Biochem. 1980, 49:593-626.